Patents by Inventor Rashmi Tiwari-Pandey

Rashmi Tiwari-Pandey has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOUNDS FOR TREATING PROLIFERATOR-ACTIVATED RECEPTORS (PPAR) MEDIATED DISEASES OR CONDITIONS
    Publication number: 20220378744
    Abstract: Novel compounds, in particular novel peroxisome proliferator-activated receptor (PPAR) agonist compounds, are provided. Pharmaceutical formulations for treating PPAR mediated disorder or condition are also provided. The formulations may be a combination of cannabinoids and the PPAR agonist compounds. The PPAR mediated disorder or condition may include inflammation related diseases such as psoriasis, psoriatic arthritis and atopic dermatitis.
    Type: Application
    Filed: April 22, 2022
    Publication date: December 1, 2022
    Inventors: Safwat M. RABEA, Kaiji HU, Rakshit D. KODEKALRA, K.K. Durgaro VISHWANADHAM, Rashmi TIWARI-PANDEY, Nihar PANDEY
  • Cannabinoid receptor agonists and serine hydrolase enzyme inhibitor based anxiolytic therapeutic product
    Patent number: 11147805
    Abstract: Provided herein are formulations for treating affective mood disorders. The formulations comprise one or more than one CB receptor agonist and one or more than one serine hydrolase enzyme inhibitor.
    Type: Grant
    Filed: February 7, 2019
    Date of Patent: October 19, 2021
    Assignee: Medipure Pharmaceuticals Inc.
    Inventors: Rashmi Tiwari-Pandey, Rakshit Devappa Kodekalra, Nihar R. Pandey
  • CANNABINOID RECEPTOR AGONISTS AND SERINE HYDROLASE ENZYME INHIBITOR BASED ANXIOLYTIC THERAPEUTIC PRODUCT
    Publication number: 20200253947
    Abstract: Provided herein are formulations for treating affective mood disorders. The formulations comprise one or more than one CB receptor agonist and one or more than one serine hydrolase enzyme inhibitor.
    Type: Application
    Filed: February 7, 2019
    Publication date: August 13, 2020
    Applicant: Medipure Pharmaceuticals Inc.
    Inventors: Rashmi Tiwari-Pandey, Rakshit Devappa Kodekalra, Nihar R. Pandey
  • CANNABINOID RECEPTOR AGONISTS AND SERINE HYDROLASE ENZYME INHIBITOR BASED ANXIOLYTIC THERAPEUTIC PRODUCT
    Publication number: 20200253948
    Abstract: Provided herein are formulations for treating affective mood disorders. The formulations comprise one or more than one CB receptor agonist and one or more than one serine hydrolase enzyme inhibitor.
    Type: Application
    Filed: October 31, 2019
    Publication date: August 13, 2020
    Applicant: Medipure Pharmaceuticals Inc.
    Inventors: Rashmi TIWARI-PANDEY, Rakshit Devappa KODEKALRA, Nihar R. PANDEY